EI- Nile for Pharmaceuticals and Chemical Industries Balance Sheet Health
Financial Health criteria checks 4/6
EI- Nile for Pharmaceuticals and Chemical Industries has a total shareholder equity of EGP491.3M and total debt of EGP213.4M, which brings its debt-to-equity ratio to 43.4%. Its total assets and total liabilities are EGP1.2B and EGP710.5M respectively. EI- Nile for Pharmaceuticals and Chemical Industries's EBIT is EGP229.9M making its interest coverage ratio 14.5. It has cash and short-term investments of EGP44.4M.
Key information
43.4%
Debt to equity ratio
ج.م213.38m
Debt
Interest coverage ratio | 14.5x |
Cash | ج.م44.37m |
Equity | ج.م491.33m |
Total liabilities | ج.م710.54m |
Total assets | ج.م1.20b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NIPH's short term assets (EGP1.0B) exceed its short term liabilities (EGP548.4M).
Long Term Liabilities: NIPH's short term assets (EGP1.0B) exceed its long term liabilities (EGP162.1M).
Debt to Equity History and Analysis
Debt Level: NIPH's net debt to equity ratio (34.4%) is considered satisfactory.
Reducing Debt: NIPH's debt to equity ratio has increased from 42.1% to 43.4% over the past 5 years.
Debt Coverage: NIPH's debt is not well covered by operating cash flow (0.2%).
Interest Coverage: NIPH's interest payments on its debt are well covered by EBIT (14.5x coverage).